Welcome to our dedicated page for Waystar Holding news (Ticker: WAY), a resource for investors and traders seeking the latest updates and insights on Waystar Holding stock.
Waystar Holding Corp. (Nasdaq: WAY) is a healthcare payment software company whose news flow centers on technology innovation, financial performance, and capital markets activity. As a provider of mission-critical, cloud-native software for healthcare payments, Waystar regularly issues updates about its AI capabilities, platform enhancements, and the impact of its solutions on revenue cycle operations for providers.
Readers of this news page can expect coverage of announcements related to Waystar AltitudeAI™, agentic intelligence, and the company’s broader vision for an autonomous revenue cycle. Recent communications have highlighted how Waystar’s AI-powered platform is used to prevent claim denials, accelerate denial appeals, improve reimbursement recovery, and reduce administrative workload across clinical documentation and billing workflows.
Waystar also reports quarterly and annual financial results, which are typically accompanied by earnings press releases and Form 8-K filings. These updates may include discussions of revenue trends, margins, key operating metrics, and guidance, as well as commentary from management on business performance. In addition, the company announces participation in investor conferences and presentations at major healthcare and technology events, reflecting its engagement with the investment community.
Corporate development and strategic transactions are another important theme in Waystar’s news. The company has announced the acquisition and integration of Iodine Software, describing how the combination of large clinical and financial datasets enhances its AI platform and expands its total addressable market. Index-related news, such as Waystar’s inclusion in the S&P SmallCap 600® Index, also appears in its releases.
For investors, analysts, and healthcare professionals, this news page provides a centralized view of Waystar’s product innovations, AI initiatives, financial disclosures, capital structure developments, and strategic milestones. Regular visits can help readers follow how the company’s software platform and data assets are evolving within the U.S. healthcare payment landscape.
Waystar Holding Corp. (Nasdaq: WAY), a leading healthcare payment software provider, has announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference. CEO Matt Hawkins will deliver a presentation on Monday, January 13, 2025, at 11:15 a.m. PT.
The company will provide real-time access to the presentation through a live webcast on their Investor Relations website. For those unable to attend or watch live, a recording will be made available on the same platform following the event. Interested parties can access the webcast at https://investors.waystar.com/news-events/events.
Waystar Holding Corp. (WAY) announced amendments to its first lien credit agreement, enhancing its financial flexibility and reducing borrowing costs. The company's term loan interest rate has been reduced to adjusted SOFR +2.25% from SOFR +2.75%. Additionally, the revolving credit facility has been expanded to $400 million from $342.5 million, with its interest rate lowered to adjusted SOFR +1.75% from SOFR +2.25%.
These changes follow Waystar's IPO on June 7, 2024, where proceeds were used to reduce debt, and a previous loan repricing on June 27, 2024.
Waystar Holding Corp. (Nasdaq: WAY) has been named one of Forbes' Most Trusted Companies in America, placing among the top 15% of 2,000 evaluated public companies. The recognition was based on four key categories: customer trust, employee trust, investor trust, and media sentiment.
The healthcare payment software provider has demonstrated strong performance in client satisfaction, with 98% of clients rating Waystar's trust delivery as very well or extremely well. The company ranked #1 versus competitors in client satisfaction and product innovation.
In 2024, Waystar has received multiple accolades including Fortune's Best Workplaces in Health Care, the Healthcare Payments Innovation Award from MedTech Breakthrough, and multiple Gold Stevie® Awards for its cloud-based platform and AI leadership. The company serves over 1 million providers through its AI-driven automation and cloud-based software platform.
Waystar Holding Corp (Nasdaq: WAY), a healthcare payment software provider, has announced its participation in two upcoming investor conferences. CEO Matt Hawkins will present at the Evercore ISI HealthCONx Conference on December 4, 2024, at 1:20 p.m. ET, and the Barclays 22nd Annual Global Technology Conference on December 12, 2024, at 11:00 a.m. PT. Both presentations will be available via live webcasts on Waystar's Investor Relations website, with recordings accessible afterward.
Waystar Holding Corp. (Nasdaq: WAY) announced its third-quarter 2024 results, highlighting a 22% year-over-year revenue growth to $240 million, with a net income of $5.4 million and a net income margin of 2%. Non-GAAP net income was $25.3 million, and adjusted EBITDA was $96.7 million, representing a margin of 40%. The company reported a cash flow from operations of $79 million and unlevered free cash flow of $89 million. Key metrics include 1,173 clients contributing over $100,000 in LTM revenue, a 14% increase year-over-year, and a net revenue retention rate of 109%. Subscription revenue grew by 16% to $118 million, while volume-based revenue increased by 28% to $120.7 million. For the fiscal year 2024, Waystar projects total revenue between $926 million and $934 million, adjusted EBITDA between $374 million and $378 million, and non-GAAP net income between $47 million and $50 million.
Waystar Holding Corp. (Nasdaq: WAY), a leading healthcare payment software provider, has announced its plans to release third quarter 2024 financial results on November 6, 2024, after market close. The company will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the financial outcomes. For those interested in participating, a live audio webcast of the conference call will be accessible through Waystar's investor relations website. Additionally, the webcast will be archived on the site for those unable to attend in real-time, ensuring all stakeholders have access to the information.
Waystar Holding Corp. (Nasdaq: WAY) and Modern Healthcare have released a study on AI's impact in healthcare payments. The research, surveying over 60 senior executives and finance leaders, reveals significant benefits of AI adoption:
Key findings:
- 75% report positive ROI from AI in healthcare payments
- 90% plan to increase AI investments soon
- AI adoption has improved staff productivity, revenue, and patient satisfaction
- 66% expect to invest in generative AI within 18 months
The study highlights AI's potential to simplify healthcare payments, automate tasks, and allow providers to focus more on patient care. Waystar's CEO, Matt Hawkins, emphasized the company's leadership in innovation and focus on delivering ROI across their software platform.
Waystar Holding Corp. (Nasdaq: WAY), a leading healthcare payment software provider, has been honored with multiple Stevie® Awards at the 2024 International Business Awards® (IBAs). The company received a Gold Stevie® Award for Company of the Year in the healthcare category and for the best Payments Solution. Additionally, Waystar earned two Silver Stevie® Awards for its AI capabilities in healthcare applications and digital automation.
CEO Matt Hawkins emphasized the company's focus on leveraging AI to improve payment processes for healthcare providers and patients. Waystar's recent collaboration with Google Cloud to develop generative AI applications further demonstrates its commitment to innovation. The awards, selected from over 3,600 nominations, follow other industry recognitions in 2024, including the Healthcare Payments Innovation Award from MedTech Breakthrough.
Waystar Holding Corp. (Nasdaq: WAY), a leading healthcare payment software provider, has announced that CEO Matt Hawkins will speak at the Canaccord Genuity Growth Conference on Tuesday, August 13, 2024, at 10:00 a.m. ET. This presentation marks an important opportunity for Waystar to showcase its growth and innovations in the healthcare technology sector.
Investors and interested parties can view the presentation live on Waystar's Investor Relations website. For those unable to attend the live event, a recording will be made available on the same platform after the conference. This event underscores Waystar's commitment to transparency and engagement with its stakeholders, providing insights into the company's strategies and market position.
Waystar Holding Corp. (Nasdaq: WAY), a provider of healthcare payment software, announced its Q2 2024 earnings.
Revenue grew by 20% year-over-year to $234.5 million. However, the company reported a net loss of $27.7 million with a net loss margin of (11.8)%. Non-GAAP net income was reported at $5.0 million.
Adjusted EBITDA was $93.9 million with a margin of 40%. Cash flow from operations amounted to $15.5 million, and unlevered free cash flow reached $50.3 million.
Key metrics included 1,117 clients contributing over $100,000 in LTM revenue, up by 9% year-over-year, and a net revenue retention rate of 108%.
The company forecasts full fiscal year 2024 total revenue between $902 million and $918 million, adjusted EBITDA between $360 million and $368 million, and non-GAAP net income between $36 million and $42 million.